Cargando…
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
Schizophrenia is a severe psychiatric disorder characterized by emotional, behavioral and cognitive disturbances, and the treatment of schizophrenia is often complicated by noncompliance and pharmacoresistance. The search for the pathophysiological mechanisms underlying schizophrenia has resulted in...
Autores principales: | Ľupták, Matej, Michaličková, Danica, Fišar, Zdeněk, Kitzlerová, Eva, Hroudová, Jana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311514/ https://www.ncbi.nlm.nih.gov/pubmed/34327122 http://dx.doi.org/10.5498/wjp.v11.i7.277 |
Ejemplares similares
-
Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism—In Vitro Study
por: Ľupták, Matej, et al.
Publicado: (2022) -
Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity
por: Ľupták, Matej, et al.
Publicado: (2023) -
Plasma cortisol in Alzheimer’s disease with or without depressive symptoms
por: Zvěřová, Martina, et al.
Publicado: (2013) -
Age-Dependent Alterations in Platelet Mitochondrial Respiration
por: Fišar, Zdeněk, et al.
Publicado: (2023) -
Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová, Martina, et al.
Publicado: (2019)